Vanteron R&DP.S.A.
Research and experimental development in natural sciences and engineering
KRS: NIP: REGON:
Overview
Status
Active
Registry date
2026-10-21
Registered address
ul. Mokotowska 1, 00-640 Warszawa, Poland
Industry
Authorized Representatives
Agnieszka Siołekage 40 – President of the Management Board
Manner of representation
The company is represented by each member of the management board independently, both in judicial and extrajudicial matters.
Beneficial owners
No beneficial owners recorded for the company Vanteron R&D.
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Novo Nordisk Pharmasp. z o.o. | $126,524,177.00 | novonordisk.pl | ||
| Centrum Edukacji Medycznejsp. z o.o. | $2,838,215.80 | cem-med.pl | ||
| Agencja Rynku EnergiiS.A. | $2,676,821.15 | are.waw.pl | ||
| DR Koziejsp. z o.o. + limited partnership | $770,078.78 | drkoziej.com | ||
| Florabosp. z o.o. | $765,897.40 | florabo.pl | ||
| FamicordtxS.A. | $589,673.84 | famicordtx.com | ||
| Care Access Polskasp. z o.o. | $305,248.06 | careaccess.pl | ||
| ETG Zamośćsp. z o.o. | $260,151.02 | etg-network.com | ||
| Codeit4us Rndsp. z o.o. | $152,435.96 | codeit4us.com | ||
| Bio2materialssp. z o.o. | $14,121.59 | bio2materials.com |
FAQ
Last updated: 2026-10-26